Summit Therapeutics
SMMT
S$35.30
Share price
-4.26%
Change (1 day)
143.85%
Change (1 year)
Categories
Market capitalization of Summit Therapeutics (SMMT)
Market cap: S$26.21 Billion
As of July 2025 Summit Therapeutics has a market cap of S$26.21 Billion. This makes Summit Therapeutics the world's 1047th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Summit Therapeutics from 2015 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | S$26.21 B | 43.64% |
| 2024 | S$18.25 B | 655.58% |
| 2023 | S$2.41 B | 110.61% |
| 2022 | S$1.14 B | 222.79% |
| 2021 | S$0.35 B | -30.52% |
| 2020 | S$0.51 B | 252.96% |
| 2019 | S$0.14 B | 460.6% |
| 2018 | S$25.84 M | -88.31% |
| 2017 | S$0.22 B | 45.19% |
| 2016 | S$0.15 B | -23.6% |
| 2015 | S$0.19 B |
End of Day market cap according to different sources
On Jul 28th, 2025 the market cap of Summit Therapeutics was reported to be:
S$26.21 Billion
S$26.21 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | S$1.75 B | -93.32% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | S$7.92 B | -69.76% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | S$0.28 B | -98.90% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | S$0.15 B | -99.39% | 🇺🇸 USA |